Syncoilin upregulation in muscle of patients with neuromuscular disease

Muscle and Nerve

Volumn 32, Issue 6, 2005, Pages 715-725

  Brown, Susan C ^a   Torelli, Silvia ^a   Ugo, Isabella ^a   De Biasia, Floriana ^a   Howman, Emily V ^b   Poon, Ellen ^b   Britton, Joanna ^b   Davies, Kay E ^b   Muntoni, Francesco ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Desmin; Intermediate filament protein; Muscular dystrophy; Neuromuscular disease; Syncoilin

Indexed keywords

CALCIUM ION; DESMIN; DYSTROPHIN; GENE PRODUCT; RYANODINE RECEPTOR; SYNCOILIN; UNCLASSIFIED DRUG; UTROPHIN;

ANTIBODY LABELING; ARTICLE; BECKER MUSCULAR DYSTROPHY; CALCIUM TRANSPORT; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FETUS; GENE MUTATION; GENETIC DISORDER; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMEDIATE FILAMENT; MUSCLE DISEASE; MUSCULAR DYSTROPHY; NEUROLOGIC DISEASE; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; PROGRESSIVE MUSCULAR ATROPHY; PROTEIN ANALYSIS; STATISTICAL SIGNIFICANCE;

ANIMALS; BLOTTING, WESTERN; CARRIER PROTEINS; DESMIN; DYSTROGLYCANS; DYSTROPHIN-ASSOCIATED PROTEINS; FETUS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICE; MICE, INBRED MDX; MUSCLE, SKELETAL; MYOSINS; NEURAL CELL ADHESION MOLECULES; NEUROMUSCULAR DISEASES; UP-REGULATION;

EID: 28544452131     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20431     Document Type: Article

References (23)

1. Bonilla E, Samitt CE, Miranda AF, Hays AP, Salviati G, DiMauro S, et al. Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell 1988;54:447-452.
2. Bonnemann CG, Thompson TG, van derVen PF, Goebel HH, Warlo I, Vollmers B, et al. Filamin C accumulation is a strong but nonspecific immunohistochemical marker of core formation in muscle. J Neurol Sci 2003;206:71-78.
3. Bork P, Sudol M. The WW domain: a signalling site in dystrophin? Trends Biochem Sci 1994;19:531-533.
4. Bredt DS. Knocking signalling out of the dystrophin complex. Nat Cell Biol 1999;1:E89-E91.
5. Brockington M, Sewry CA, Herrmann R, Naom I, Dearlove A, Rhodes M, et al. Assignment of a form of congenital muscular dystrophy with secondary merosin deficiency to chromosome Iq42. Am J Hum Genet 2000;66:428-435.
6. Bushby KM. The limb-girdle muscular dystrophies-multiple genes, multiple mechanisms. Hum Mol Genet 1999;8:1875-1882.
7. Chou YH, Goldman RD. Intermediate filaments on the move. J Cell Biol 2000;150:F101-F106.
8. Cohn RD, Campbell KP. Molecular basis of muscular dystrophies. Muscle Nerve 2000;23:1456-1471.
9. Ervasti JM, Campbell KP. Membrane organization of the dystrophin-glycoprotein complex. Cell 1991;66:1121-1131.
10. Feasson L, Stockholm D, Freyssenet D, Richard I, Duguez S, Beckmann JS, et al. Molecular adaptations of neuromuscular disease-associated proteins in response to eccentric exercise in human skeletal muscle. J Physiol (Lond) 2002;543:297-306.
11. Grady RM, Grange RW, Lau KS, Maimone MM, Nichol MC, Stull JT, et al. Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol 1999;1:215-220.
12. Howman EV, Sullivan N, Poon EP, Britton JE, Hilton-Jones D, Davies KE. Syncoilin accumulation in two patients with desmin-related myopathy. Neuromuscul Disord 2003;13:42-48.
13. Ilsley JL, Sudol M, Winder SJ. The WW domain: linking cell signalling to the membrane cytoskeleton. Cell Signal 2002;14:183-189.
14. Li Z, Mericskay M, Agbulut O, Butler-Browne G, Carlsson L, Thornell LE, et al. Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle. J Cell Biol 1997;139:129-144.
15. Lumeng C, Phelps S, Crawford GE, Walden PD, Barald K, Chamberlain JS. Interactions between beta 2-syntrophin and a family of microtubule-associated serine/threonine kinases. Nat Neurosci 1999;2:611-617.
16. Nawrotzki R, Loh NY, Ruegg MA, Davies KE, Blake DJ. Characterisation of alpha-dystrobrevin in muscle. J Cell Sci 1998;111:2595-2605.
17. Newey SE, Gramolini AO, Wu J, Holzfeind P, Jasmin BJ, Davies KE, et al. A novel mechanism for modulating synaptic gene expression: differential localization of alpha-dystrobrevin transcripts in skeletal muscle. Mol Cell Neurosci 2001;17:127-140.
18. Newey SE, Howman EV, Ponting CP, Benson MA, Nawrotzki R, Loh NY, et al. Syncoilin, a novel member of the intermediate filament superfamily that interacts with alpha-dystrobrevin in skeletal muscle. J Biol Chem 2001;276:6645-6655.
19. Petrof BJ. The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy. Mol Cell Biochem 1998;179:111-123.
20. Poon E, Howman EV, Newey SE, Davies KE. Association of syncoilin and desmin: linking intermediate filament proteins to the dystrophin-associated protein complex. J Biol Chem 2002;277:3433-3439.
21. Sadoulet-Puccio HM, Feener CA, Schaid DJ, Thibodeau SN, Michels W, Kunkel LM. The genomic organization of human dystrobrevin. Neurogenetics 1997;1:37-42.
22. Sewry CA, Muller C, Davis M, Dwyer JS, Dove J, Evans G, et al. The spectrum of pathology in central core disease. Neuromuscul Disord 2002;12:930-938.
23. Yu JG, Thornell LE. Desmin and actin alterations in human muscles affected by delayed onset muscle soreness: a high resolution immunocytochemical study. Histochem Cell Biol 2002;118:171-179.